📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: TheracosBio

1.1 - Company Overview

TheracosBio Logo

TheracosBio

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of Brenzavvy, an FDA-approved oral treatment for type 2 diabetes, with a focus on accessible medications.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to TheracosBio

Diakine Therapeutics Logo

Diakine Therapeutics

HQ: United States Website
  • Description: Provider of novel immune modulators for the treatment of diabetes and related complications, commercializing therapeutics with potential to stop disease progression and reverse damage; a development-stage company with programs including adjunct therapy to islet.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Diakine Therapeutics company profile →
Jaguar Gene Therapy Logo

Jaguar Gene Therapy

HQ: United States Website
  • Description: Provider of AAV-based gene therapy candidates for severe genetic diseases, including JAG101, a preclinical therapy delivering the functional GALT gene via AAV9 for Type 1 galactosemia; JAG201, an investigational therapy targeting SHANK3-related disorders such as autism spectrum disorder and Phelan-McDermid syndrome; and JAG301, a preclinical therapy producing functional beta cells through transdifferentiation for Type 1 diabetes.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Jaguar Gene Therapy company profile →
Animas Logo

Animas

HQ: United States Website
  • Description: Provider of external insulin pumps for people with diabetes, designing, developing, manufacturing, and selling these devices. Believed to be the second-largest supplier in the U.S. by new pump placements. Introduced the R1000 in July 2000 and expects to begin shipping its third-generation pump.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Animas company profile →
Elcelyx Logo

Elcelyx

HQ: United States Website
  • Description: Provider of nutrient sensing-based products in development for weight management and obesity-related metabolic disorders.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Elcelyx company profile →
Intarcia Logo

Intarcia

HQ: United States Website
  • Description: Provider of long-term therapies for chronic diseases, offering the MEDICITM Drug Delivery System for twice-yearly subcutaneous osmotic implants, ITCA 650 (twice-yearly exenatide implant) for type 2 diabetes, and an Ionic Liquid Platform converting injectable biologics and peptides into oral therapies; pipeline includes i2o-105s (long-acting GLP-1 receptor agonist), i2o-107 (long-acting amylin), and i2o-110 (dual agonist) for type 2 diabetes, obesity, and NASH.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Intarcia company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for TheracosBio

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to TheracosBio

2.2 - Growth funds investing in similar companies to TheracosBio

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for TheracosBio

4.2 - Public trading comparable groups for TheracosBio

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to TheracosBio

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About TheracosBio

What does TheracosBio do?

TheracosBio is a provider of Brenzavvy, an FDA-approved oral treatment for type 2 diabetes, with a focus on accessible medications.

Who are TheracosBio's competitors?

TheracosBio's competitors and similar companies include Diakine Therapeutics, Jaguar Gene Therapy, Animas, Elcelyx, and Intarcia.

Where is TheracosBio headquartered?

TheracosBio is headquartered in United States.

How many employees does TheracosBio have?

TheracosBio has 1,000 employees 🔒.

When was TheracosBio founded?

TheracosBio was founded in 2010 🔒.

What sector and industry vertical is TheracosBio in?

TheracosBio is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for TheracosBio

Who are the top strategic acquirers in TheracosBio's sector and industry

Top strategic M&A buyers and acquirers in TheracosBio's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for TheracosBio?

Top strategic M&A buyers groups and sectors for TheracosBio include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in TheracosBio's sector and industry vertical

Which are the top PE firms investing in TheracosBio's sector and industry vertical?

Top PE firms investing in TheracosBio's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in TheracosBio's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in TheracosBio's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in TheracosBio's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to TheracosBio include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in TheracosBio's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for TheracosBio?

The key public trading comparables and valuation benchmarks for TheracosBio include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for TheracosBio for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for TheracosBio with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in TheracosBio's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for TheracosBio with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in TheracosBio's' sector and industry vertical?

Access recent funding rounds and capital raises in TheracosBio's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for TheracosBio